Hua Medicine Announces 2026 Interim Results

– Sales of HuaTangNing reached 3.055 million packs in the first half of 2026, representing a 73% year-on-year increase; revenue hit RMB378.9 million, up 74% year-on-year. The in-house commercialization drive maintained robust growth with continuously improved operational efficiency. – Expanded manufacturing scale lifted gross profit margin substantially to 61.8%, a year-on-year rise of 7.6…